Figure 1.
Outcomes of patients with AML according to the number of CRs/CRis (first vs second) at allogeneic HSCT (n = 580). (A) CIR, (B) NRM, (C) RDS, and (D) OS.

Outcomes of patients with AML according to the number of CRs/CRis (first vs second) at allogeneic HSCT (n = 580). (A) CIR, (B) NRM, (C) RDS, and (D) OS.

Close Modal

or Create an Account

Close Modal
Close Modal